Literature DB >> 1498488

The relationship of estrogen receptor status to DNA ploidy in breast cancer.

A Tsuchiya1, M Nihei, Y Ando, S Suzuki, I Kimijima, R Abe.   

Abstract

The relationship of estrogen receptor (ER) status to DNA ploidy was investigated in 121 patients with breast cancer who underwent surgery. Lymph node status was evaluated histologically and ER levels were determined by the dextran-coated charcoal method, with a level of 3 fmol/mg.protein being considered positive. Flow cytometric DNA content was analyzed using paraffin-embedded tissue blocks. Sixty-three percent of the specimens were ER+, while 37 percent were negative. Sixty-one patients (50.4 percent) were diploid and 60 aneuploid. A statistically significant correlation between the ER positivity rate and diploid DNA was found. Higher ER levels were seen in the postmenopausal patients with diploid tumors than in those with aneuploid tumors and there was a significant tendency for ER levels to be higher in the diploid tumors. Nodal status was not correlated with ER positivity or ploidy pattern. The present results indicate that ER levels are correlated with DNA ploidy, and reflect the degree of functional differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1498488     DOI: 10.1007/bf00311332

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  30 in total

1.  Oestrogen receptors in breast cancer: a changing concept.

Authors:  G Leclercq; J C Heuson; M C Deboel; W H Mattheiem
Journal:  Br Med J       Date:  1975-01-25

2.  Two-stage model for carcinogenesis: Epidemiology of breast cancer in females.

Authors:  S H Moolgavkar; N E Day; R G Stevens
Journal:  J Natl Cancer Inst       Date:  1980-09       Impact factor: 13.506

3.  Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.

Authors:  J S Meyer; B R Rao; S C Stevens; W L White
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

4.  Progesterone and estrogen receptors as prognostic variables in breast cancer.

Authors:  B H Mason; I M Holdaway; P R Mullins; L H Yee; R G Kay
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

5.  Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.

Authors:  K S McCarty; T K Barton; B F Fetter; B H Woodard; J A Mossler; W Reeves; J Daly; W E Wilkinson; K S McCarty
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

6.  Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.

Authors:  S M Thorpe; C Rose; B B Rasmussen; H T Mouridsen; T Bayer; N Keiding
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

7.  Correlation of primary breast cancer histopathology and estrogen receptor content.

Authors:  E R Fisher; C K Osborne; W L McGuire; C Redmond; W A Knight; B Fisher; G Bannayan; A Walder; E J Gregory; A Jacobsen; D M Queen; D E Bennett; H C Ford
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

8.  Relationship between proliferative activity and estrogen receptors in breast cancer.

Authors:  R Silverstrini; M G Daidone; G Di Fronzo
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

9.  Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis.

Authors:  A Reiner; G Reiner; J Spona; M Schemper; J H Holzner
Journal:  Cancer       Date:  1988-03-15       Impact factor: 6.860

10.  Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.

Authors:  G M Clark; C K Osborne; W L McGuire
Journal:  J Clin Oncol       Date:  1984-10       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.